ArticleGates open research2020
Protecting the vulnerable during COVID-19: Treating and preventing chronic disease disparities.
Article in Gates open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 22 citations in OpenAlex.
- The impact of COVID-19 on mortality among diabetic and hypertensive individuals in coastal communities in Bangladesh: evidence from chakaria health and demographic surveillance system.Population health metrics · 2026Article
- Trajectories of sleep disturbance and self-management of chronic conditions during COVID-19 among middle-aged and older adults.Scientific reports · 2025Article
- Impact of COVID-19 on perceived wellbeing, self-management and views of novel modalities of care among medically vulnerable patients in Singapore.Chronic illness · 2023Article
- A review of disparities in peripheral artery disease and diabetes-related amputations during the COVID-19 pandemic.Seminars in vascular surgery · 2023Review
- Task shifting healthcare services in the post-COVID world: A scoping review.PLOS global public health · 2023Article
- Article
- Self-care of hypertension of older adults during COVID-19 lockdown period: a randomized controlled trial.Clinical hypertension · 2022Article
- The impact of COVID-19 on chronic disease management in primary care: lessons for Australia from the international experience.The Medical journal of Australia · 2022Article
- The Impact of COVID-19 Pandemic on Outpatient Visits for All-Cause and Chronic Diseases in Korea: A Nationwide Population-Based Study.International journal of environmental research and public health · 2022Article
- A Personalized Mobile Health Program for Type 2 Diabetes During the COVID-19 Pandemic: Single-Group Pre-Post Study.JMIR diabetes · 2021Article
- Toilet Paper, Minced Meat and Diabetes Medicines: Australian Panic Buying Induced by COVID-19.International journal of environmental research and public health · 2021Article
- Impact of the COVID-19 Pandemic on Patients Affected by Non-Communicable Diseases in Europe and in the USA.International journal of environmental research and public health · 2021Article
- Call for Action to Address Equity and Justice Divide During COVID-19.Frontiers in psychiatry · 2020Article
- Expected Impacts of COVID-19: Considering Resource-Limited Countries and Vulnerable Population.Frontiers in public healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has exacerbated health disparities across ethnic and socioeconomic groups. Non-communicable diseases (NCDs) - such as hypertension, diabetes, and obstructive lung diseases - are key drivers of this widening gap, because they disproportionately afflict vulnerable populations. Vulnerable populations with non-communicable diseases, in turn, are disproportionately affected by COVID-19 itself - but also at increased risk of poor outcomes from those underlying conditions. Proven strategies for NCD control must be adapted to help vulnerable patients react to these dual threats. We detail six key policy interventions - task shifting, workforce protection, telehealth and mobile services, insurance restructuring and increased funding for NCDs, prescription policies for NCDs and community partnerships - to bridge this care gap. Long-term integration of these care models post-COVID-19 may prevent care shocks during future pandemics, bolstering emerging universal primary care models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.